There is research data that supports extended use for most methods of long-acting reversible contraception (LARC) available in the US. Studies have shown that the hormonal IUD (Liletta), as well as the copper IUD (Paragard), and the contraceptive implant (Nexplanon) are effective beyond their FDA-approved duration. This document outlines those research findings.